This fact sheet outlines the Advancing Maternal Immunization (AMI) collaboration, which brings together diverse stakeholders to improve infant health and survival through maternal immunization. Currently focused on respiratory syncytial virus, AMI is identifying viable pathways to enable informed decision-making and rapid launch of maternal vaccines, particularly in resource-limited settings.

Publication date: September 2017

Region: Global

This slide provides a snapshot of the respiratory syncytial virus (RSV) vaccine and monoclonal antibody (mAb) technology landscape, in the effort to track the development of RSV vaccine and mAb candidates and provide a summary of the various vaccine approaches being worked on worldwide.

Publication date: September 2017

Region: Global

This fact sheet describes the work and approach of the Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland, the Oxford Vaccine Group at Oxford University, and PATH. TyVAC aims to accelerate the introduction of new typhoid conjugate vaccines as part of an integrated approach to reduce the burden of typhoid.

Publication date: August 2017

Region: Global

Since the beginning of the pandemic, PATH has worked in more than 35 countries to reduce the global impact of HIV/AIDs. This fact sheet outlines the range of PATH’s work to address HIV/AIDS, from developing new diagnostics to improving service delivery.

Publication date: August 2017

Region: Global

PATH and partners are developing iOWH032 as a complement to oral rehydration solution for diarrheal disease treatment. Acting via inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel, iOWH032 is a novel, low-molecular-weight compound intended to reduce fluid and electrolyte loss in cases of cholera toxin-induced secretory diarrhea.

Publication date: August 2017

Region: Global

Oxygen is listed on the World Health Organization’s Model List of Essential Medicines (EML) and EML for children. This infographic, aimed at advocates and decision-makers, describes the “what,” “where,” “how,” and “how much” behind oxygen programs, and urges countries to align national policies to prioritize oxygen therapy across the entire health system.

Publication date: August 2017

Region: Global

Part of series: Oxygen technologies

This report presents the results of a field evaluation assessing usability, acceptability, and operational feasibility of the Georgia Tech microarray patch. The evaluation used mock microarray patches, without microarrays, which were applied during the course of routine care to women attending antenatal care visits and children attending expanded program on immunization visits.

Publication date: August 2017

Region: Global

The Drug Development program represents a key innovation platform at PATH. Guided by a passion for health equity, we work with public- and private-sector stakeholders to develop and advance medicines for diseases disproportionately affecting women and children in low-resource settings. Areas of focus include enteric and diarrheal diseases, neglected tropical diseases, and maternal and child health.

Publication date: August 2017

Region: Global

PATH and Mountain Safety Research® Global Health co-developed the MSR SE200 Community Chlorine Maker (MSR SE200), a portable, affordable device that makes chlorine on demand with the push of a button for safe, drinkable water.

Publication date: July 2017

Region: Global

Part of series: Technology Updates

Part of the Technology Updates series, this fact sheet describes PATH’s work on freeze-preventive vaccine carriers to address the problem of vaccines freezing during transport.

Publication date: July 2017

Region: Global

Part of series: Technology Updates

Following a user-centered design approach, PATH developed a portable hand-wash station. This fact sheet details the technology solution specifications and current status of the project.

Publication date: July 2017

Region: Global

PATH’s Healthy Markets project, funded by USAID, has worked with the Ministry of Health, public and private clinics, and community-based organizations to introduce HIV self-testing into Vietnam for the first time. HIV self-testing offers a private, confidential, and convenient testing option, particularly those who face social barriers to HIV services. This fact sheet provides early results of this pilot program.

Publication date: July 2017

Region: Asia, North America and Europe, Global

This year's annual report features our annual financial overview, PATH’s leadership and office locations, and a list of PATH’s funders and supporters.

Publication date: July 2017

Region: Global

Part of series: Annual reports

This issue of the PATH Malaria Learning Series explores PATH’s innovation pipeline, which includes promising projects in vaccines, diagnostics, drugs, and system and service innovations. Defeating malaria will require a range of innovative strategies and solutions, and PATH’s innovation pipeline provides encouraging examples of the work that is now under way.

Publication date: July 2017

Region: Global

Part of series: Malaria learning series

PATH’s Healthy Markets project, funded by USAID, has introduced oral HIV pre-exposure prophylaxis (PrEP)—a powerful HIV prevention tool—into Vietnam for the first time. PATH is working with the Vietnam Ministry of Health, public and private clinics, and community-based organizations to enable those most at risk of HIV to access PrEP and prevent new HIV infections.

Publication date: July 2017

Region: Asia, North America and Europe, Global

PATH’s Reach Campaign is a $125 million fundraising initiative to accelerate progress toward a world where health is within reach for everyone. This report provides an update on the campaign as of summer 2017 and highlights work PATH is advancing, thanks to support from our donors.

Publication date: July 2017

Region: Global

Part of series: Reports to contributors

Part of the Technology Updates series, this fact sheet describes PATH's work, in collaboration with MSR® Global Health, to develop the SE Flow, an innovative onsite chlorine generator for drinking water treatment and infection prevention and control.

Publication date: July 2017

Region: Global

Part of series: Technology Updates

Advocacy for Better Health (ABH) advances policies, budgets, and programs for a variety of health topics, including HIV and AIDS, malaria, tuberculosis, nutrition, maternal, newborn and child health, and sexual and reproductive health. In addition, ABH focuses on three cross-cutting priorities: domestic financing, commodity security, and human resources for health. These briefs highlight ABH priority issue areas and outline calls to action.

Publication date: June 2017

Region: Africa, Global

The Health Data Visualization Selection Assistant helps potential data visualization customers understand the process of data visualization tool selection as well as the various features of popular data visualization products so that users may choose the tool that best fits their needs.

Publication date: June 2017

Region: Global

PATH offers a proven track record and unique qualifications for diagnosing and overcoming market challenges. This fact sheet outlines our innovative work and approach to market dynamics.

Publication date: June 2017

Region: Global